Shih‐Hsiang Ou

542 total citations
15 papers, 58 citations indexed

About

Shih‐Hsiang Ou is a scholar working on Nephrology, Surgery and Molecular Biology. According to data from OpenAlex, Shih‐Hsiang Ou has authored 15 papers receiving a total of 58 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Nephrology, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Shih‐Hsiang Ou's work include Retinal Diseases and Treatments (2 papers), Retinal Imaging and Analysis (2 papers) and Ion channel regulation and function (2 papers). Shih‐Hsiang Ou is often cited by papers focused on Retinal Diseases and Treatments (2 papers), Retinal Imaging and Analysis (2 papers) and Ion channel regulation and function (2 papers). Shih‐Hsiang Ou collaborates with scholars based in Taiwan. Shih‐Hsiang Ou's co-authors include Po‐Tsang Lee, Chien‐Liang Chen, Chun-Hao Yin, Chih‐Yang Hsu, Chien‐Wei Huang, Hua‐Chang Fang, Kang‐Ju Chou, Ho‐Ming Su, Meei‐Shyuan Lee and Jiun‐Chi Huang and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Experimental Cell Research and International Journal of Environmental Research and Public Health.

In The Last Decade

Shih‐Hsiang Ou

14 papers receiving 57 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shih‐Hsiang Ou Taiwan	5	17	16	14	14	8	15	58
Edit Gara Hungary	6	14 0.8×	9 0.6×	21 1.5×	11 0.8×	7 0.9×	11	70
Syuitsu Ueda Japan	3	30 1.8×	9 0.6×	18 1.3×	29 2.1×	4 0.5×	5	69
Matt Mellema United States	3	10 0.6×	13 0.8×	22 1.6×	4 0.3×	3 0.4×	4	57
Yingchai Zhang China	5	6 0.4×	34 2.1×	12 0.9×	15 1.1×	3 0.4×	7	78
Giuseppe Pinto Italy	5	17 1.0×	8 0.5×	22 1.6×	7 0.5×	7 0.9×	14	60
LI Fen China	5	11 0.6×	12 0.8×	21 1.5×	35 2.5×	2 0.3×	20	81
Özant Helvacı Türkiye	5	19 1.1×	4 0.3×	14 1.0×	13 0.9×	2 0.3×	31	65
Daniel Neville United Kingdom	6	8 0.5×	55 3.4×	24 1.7×	6 0.4×	4 0.5×	17	107
Umberto Gianni United States	3	18 1.1×	5 0.3×	9 0.6×	15 1.1×	23 2.9×	7	42
Daniel Phung Australia	4	31 1.8×	25 1.6×	4 0.3×	12 0.9×	6 0.8×	9	58

Countries citing papers authored by Shih‐Hsiang Ou

Since Specialization

Citations

This map shows the geographic impact of Shih‐Hsiang Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih‐Hsiang Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih‐Hsiang Ou more than expected).

Fields of papers citing papers by Shih‐Hsiang Ou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shih‐Hsiang Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih‐Hsiang Ou. The network helps show where Shih‐Hsiang Ou may publish in the future.

Co-authorship network of co-authors of Shih‐Hsiang Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Shih‐Hsiang Ou. A scholar is included among the top collaborators of Shih‐Hsiang Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shih‐Hsiang Ou. Shih‐Hsiang Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Chen, Hsin‐Yu, et al.. (2024). Associations between transfusion reactions and thromboembolism development in blood‐transfused patients: A retrospective cohort study. Transfusion. 64(8). 1428–1436.

Ou, Shih‐Hsiang, et al.. (2023). Diabetic Macular Edema Is Predictive of Renal Failure in Patients With Diabetes Mellitus and Chronic Kidney Disease. The Journal of Clinical Endocrinology & Metabolism. 109(3). 761–770. 2 indexed citations

Liao, Cheng-I, Hua‐Chang Fang, Po‐Tsang Lee, et al.. (2023). Trends in the incidence of urothelial carcinoma in Taiwan after the ban on aristolochic acid-containing Chinese herbal preparations, 2001–2018: a national population-based cohort study. Journal of Cancer Research and Clinical Oncology. 149(11). 8201–8211. 8 indexed citations

Li, Mingfeng, Shih‐Hsiang Ou, Mei‐Chen Lin, et al.. (2023). Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and the Risk of Developing Incidental Tuberculosis: A Population-Based Cohort Study. Medicina. 59(11). 1920–1920. 1 indexed citations

Lee, Po‐Tsang, et al.. (2023). Steroid-induced hypokalemic periodic paralysis: a case report and literature review. BMC Nephrology. 24(1). 70–70. 9 indexed citations

Chou, Kang‐Ju, Chih‐Yang Hsu, Chien‐Wei Huang, et al.. (2022). A new missense mutation of calcium sensing receptor with isoleucine replaced by serine at codon 857 leading to type V Bartter syndrome. Experimental Cell Research. 414(1). 113080–113080. 2 indexed citations

Ou, Shih‐Hsiang, et al.. (2022). Intravitreal Vascular Endothelial Growth Factor Inhibitor Use and Renal Function Decline in Patients with Diabetic Retinopathy. International Journal of Environmental Research and Public Health. 19(21). 14298–14298. 3 indexed citations

Ou, Shih‐Hsiang, et al.. (2022). Aluminum overload in the reverse osmosis dialysis era: does it exist?. Renal Failure. 44(1). 1596–1604. 2 indexed citations

Li, Mingfeng, Mei‐Chen Lin, Shih‐Hsiang Ou, et al.. (2022). Erythropoiesis‐stimulating agents and incident malignancy in chronic kidney and end‐stage renal disease: A population‐based study. Clinical and Translational Science. 15(9). 2195–2205. 2 indexed citations

10.

Hsu, Chih‐Yang, Chung Chang, Hsin‐Yu Chen, et al.. (2022). Infectious complications in adult patients with idiopathic minimal change nephrotic syndrome undergoing immunosuppressive therapy. Nephrology. 27(12). 953–961. 1 indexed citations

11.

Chen, Yu-Chieh, et al.. (2021). Incidence and risk factors for chronic kidney disease in patients with congenital heart disease. Pediatric Nephrology. 36(11). 3749–3756. 8 indexed citations

12.

Hsu, Chih‐Yang, Pei‐Ling Chi, Hsin-Yu Chen, et al.. (2021). Kidney bioengineering by using decellularized kidney scaffold and renal progenitor cells. Tissue and Cell. 74. 101699–101699. 8 indexed citations

13.

Ou, Shih‐Hsiang, et al.. (2021). Effect of anti-diabetic drugs in dialysis patients with diabetes: a nationwide retrospective cohort study. Cardiovascular Diabetology. 20(1). 179–179. 4 indexed citations

14.

Ou, Shih‐Hsiang, et al.. (2021). Aortic Arch Calcification and Cardiomegaly Are Associated with Overall and Cardiovascular Mortality in Hemodialysis Patients. Journal of Personalized Medicine. 11(7). 657–657. 4 indexed citations

15.

Ou, Shih‐Hsiang, Ming‐Cheng Yen, Meei‐Shyuan Lee, et al.. (2021). Vegetarian diet in dialysis patients. Medicine. 100(6). e24617–e24617. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact